Market revenue in 2023 | USD 6.6 million |
Market revenue in 2030 | USD 8.7 million |
Growth rate | 4.1% (CAGR from 2023 to 2030) |
Largest segment | Topical |
Fastest growing segment | Topical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Topical |
Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.58% in 2023. Horizon Databook has segmented the Kuwait onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of diabetes in Kuwait is significantly fueling the onychomycosis market. According to an NCBI article published in May 2021, Kuwait leading among the 6 GCC countries with 22% of its population aged between 20 and 79, serves as a significant growth driver for the Kuwait onychomycosis market.
The growing incidence of diabetes indicates a potentially expanded market for onychomycosis-related treatments, emphasizing the need for tailored strategies to address the specific healthcare challenges posed by the diabetic population in Kuwait.
Currently, the country has only one pharmaceutical manufacturing company, and there is a high demand for medicines due to the burden of various diseases, which is creating opportunities for manufacturers to invest in Kuwait.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account